Published in Cancer Weekly, August 21st, 2001
The report was published in the July 2001 issue of The Journal of Clinical Oncology. The randomized, multicenter study, evaluating 474 patients at 104 research centers in the United States and Europe, was one of the largest conducted among women suffering from ovarian cancer. The report provided the results of a Phase III clinical trial comparing Doxil and topotecan. Further studies will be required to establish the clinical benefit of Doxil.
The objective of the study was to compare the efficacy and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.